REQUEST A DEMO
Total
USD $0.00
Search more companies

Allucent (HU) Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Allucent (HU) Kft. Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

Allucent (HU) Kft. is based in Hungary. The head office is in Budapest. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on May 23, 2002. It currently has a total number of 13 (2024) employees. There was a net sales revenue drop of 15.18% reported in Allucent (HU) Kft.’s latest financial highlights for 2025. Its’ total assets recorded a growth of 60.79%. In 2025, Allucent (HU) Kft.’s net profit margin increased by 2.78%.

Headquarters
Tomori utca 34.
Budapest; Budapest; Postal Code: 1138

Contact Details: Purchase the Allucent (HU) Kft. report to view the information.

Website: http://www.pharmolam.com

Basic Information
Total Employees:
Purchase the Allucent (HU) Kft. report to view the information.
Registered Capital:
Purchase the Allucent (HU) Kft. report to view the information.
Financial Auditors:
Purchase the Allucent (HU) Kft. report to view the information.
Incorporation Date:
May 23, 2002
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Allucent (HU) Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-15.18%
Total Operating Revenue
-15.19%
Operating Profit
32.31%
EBITDA
31.54%
Net Profit/Loss for the Period
281.51%
Total Assets
60.79%
Total Equity
8.38%
Operating Profit Margin
1.65%
Net Profit Margin
2.78%
Return on Equity (ROE)
5.53%
Quick Ratio
-0.29%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?